Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
A. Galid
Observed names:
A GALID,
A Galid,
Arik Armon Galid,
Arik Galid,
Galid, A.
Institution:
Hanusch Hospital
Observed institutions:
University of Vienna,
Medical University of Graz,
Paracelsus Medical University,
Vienna General Hospital,
Hanusch Hospital,
Medical University of Vienna
show all 6
ORCID:
0009-0006-0606-4496
Observed ORCID:
0009-0006-0606-4496
OpenAlex ID:
A5015794364
A randomized double-blind multicenter phase III study offixed-dose single-administration pegfilgrastim versus daily filgrastim in patients receiving myelosuppressive chemotherapy
2002
·
M.D. Green
, H. Koelbl
, et al.
·
Annals of Oncology
·
604
Zoledronic Acid Prevents Cancer Treatment–Induced Bone Loss in Premenopausal Women Receiving Adjuvant Endocrine Therapy for Hormone-Responsive Breast Cancer: A Report From the Austrian Breast and Colorectal Cancer Study Group
2006
·
Michael F.X. Gnant
, Brigitte Mlineritsch
, et al.
·
Journal of Clinical Oncology
·
333
Impact of pretreatment thrombocytosis on survival in primary breast cancer
2003
·
Andreas Salat
, Michael Gnant
, et al.
·
Thrombosis and Haemostasis
·
156
Activity of T-DM1 in Her2-positive breast cancer brain metastases
2015
·
Rupert Bartsch
, Anna S. Berghoff
, et al.
·
Clinical & Experimental Metastasis
·
121
Axillary Lymph Node Metastases in Patients with Breast Carcinomas: Assessment with Nonenhanced versus USPIO-enhanced MR Imaging
2006
·
Mazda Memarsadeghi
, Christopher C. Riedl
, et al.
·
Radiology
·
104
Pathologic Complete Response With Six Compared With Three Cycles of Neoadjuvant Epirubicin Plus Docetaxel and Granulocyte Colony-Stimulating Factor in Operable Breast Cancer: Results of ABCSG-14
2007
·
Günther G. Steger
, Arik Galid
, et al.
·
Journal of Clinical Oncology
·
91
Polymorphisms of the endothelial nitric oxide synthase gene in women with vulvar cancer
2004
·
E RIENER
, L HEFLER
, et al.
·
Gynecologic Oncology
·
33
Current concepts and future directions in neoadjuvant chemotherapy of breast cancer
2018
·
Rupert Bartsch
, Elisabeth Bergen
, et al.
·
memo - Magazine of European Medical Oncology
·
26
PDF
6 vs. 3 cycles of epirubicin/docetaxel + G-CSF in operable breast cancer: results of ABCSG-14
2004
·
G. G. Steger
, E. Kubista
, et al.
·
Journal of Clinical Oncology
·
22
Tailored Dose-Dense Versus Standard Adjuvant Chemotherapy for High-Risk Early Breast Cancer: End-of-Study Results of the Randomized PANTHER Trial
2024
·
Alexios Matikas
, Volker Möbus
, et al.
·
Journal of Clinical Oncology
·
16
PDF
First exercise group for Turkish breast cancer patients in Vienna – a pilot project to include Turkish migrants
2019
·
Fadime Cenik
, Mohammad Keilani
, et al.
·
Disability and Rehabilitation
·
10
A final analysis from the CHOICE study examining darbepoetin alfa use for chemotherapy-induced anaemia in current European clinical practice
2012
·
S. Van Belle
, A. Swieboda-Sadlej
, et al.
·
Current Medical Research and Opinion
·
9
Estrogen replacement therapy in women with a history of breast cancer
1999
·
M Seifert
, A Galid
, et al.
·
Maturitas
·
9
Use of darbepoetin alfa in European clinical practice for the management of chemotherapy-induced anaemia in four tumour types: final data from the CHOICE study
2012
·
J.G. Aerts
, A. Swieboda-Sadlej
, et al.
·
Current Medical Research and Opinion
·
8
Safety and effectiveness of nab-paclitaxel in young and elderly patients with metastatic breast cancer: a prospective, multicenter non-interventional study
2016
·
G. Steger
, E. Petru
, et al.
·
Annals of Oncology
·
6
Prophylactic long-acting granulocyte-colony stimulating factors (G-CSF) in gynecologic malignancies: an oncologic expert statement
2015
·
Edgar Petru
, Christian F. Singer
, et al.
·
Wiener Medizinische Wochenschrift
·
6
Current practice of darbepoetin alfa in the management of haemoglobin levels in cancer patients undergoing chemotherapy – data from the CHOICE study
2011
·
S. Van Belle
, C. Karanikiotis
, et al.
·
Current Medical Research and Opinion
·
6
Orale Kontrazeptiva und Brustkrebs – ein kausaler Zusammenhang?
1998
·
M. Seifert
, A. Galid
·
Gyn�kologisch-geburtshilfliche Rundschau
·
6
Pharmacological modulation of local feedback mechanisms as a therapeutic approach in breast cancer treatment
2003
·
Singer, C.F.
, Hudelist, G.
, et al.
·
Drugs of today
·
4
Mitteilungen aus Österreich
1998
·
Paul Sevelda
, Heinrich Salzer
, et al.
·
Gyn�kologisch-geburtshilfliche Rundschau
·
4
PDF
REACHAUT: First-line (1L) ribociclib (RIB) + endocrine therapy (ET) in HR+, HER2- metastatic breast cancer (MBC) in the real-world setting.
2019
·
Christian F. Singer
, Leopold Öhler
, et al.
·
Journal of Clinical Oncology
·
3
Abstract P6-16-10: Activity of T-DM1 in HER2-positive breast cancer brain metastases
2015
·
Rupert Bartsch
, Anna S Berghoff
, et al.
·
Cancer Research
·
3
Abstract PO3-16-10: Real-world outcomes with first-line ribociclib + endocrine therapy in patients with metastatic HR+, HER2– breast cancer: Fourth interim analysis of REACH AUT trial
2024
·
Christian F. Singer
, Daniel Egle
, et al.
·
Cancer Research
·
2
195P REACH AUT: Efficacy and safety of first-line (1L) ribociclib (RIB) + endocrine therapy (ET) in HR+, HER2- metastatic breast cancer (MBC) from a real-world (RW) study: 3rd interim analysis
2022
·
C.F. Singer
, D. Egle
, et al.
·
Annals of Oncology
·
2
PDF
172P REACHAUT: Real-world study of first-line (1L) ribociclib (RIB) + endocrine therapy (ET) in HR+, HER2- metastatic breast cancer (MBC)
2020
·
C.F. Singer
, D. Egle
, et al.
·
Annals of Oncology
·
2
PDF
Show more works
View as search
Works count:
38
Citation count:
1,593
H-index:
10
I10-index:
11
Year
Topic
Type
